Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights

05/12/2024 5 min Episodio 8

Listen "Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights"

Episode Synopsis

Michelle starts with an introduction and welcome, leading into the latest Series C+ funding highlights. The episode features Tractian's funding achievements, alongside updates on Tenstorrent and Maze Therapeutics. In between, there's a brief mention of the episode's sponsor, Acme Corp. Michelle wraps up with closing remarks, providing listeners with a comprehensive overview of these significant funding developments in the startup ecosystem.

More episodes of the podcast The Growth Investor Daily Brief